NDRG1 is a prognostic biomarker in breast cancer and breast cancer brain metastasis
Abstract Brain metastases are secondary brain tumours characterised by their aggressive nature and poor prognosis. Breast cancer is one of the most common primary tumours in women to spread to the brain. A lack of biomarkers predicting likely spread to the brain and limited therapeutic interventions...
Saved in:
Main Authors: | Vaibhavi Joshi (Author), Andrew Stacey (Author), Yufan Feng (Author), Priyakshi Kalita‐de Croft (Author), Pascal HG Duijf (Author), Peter T Simpson (Author), Sunil R Lakhani (Author), Amy E McCart Reed (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2024-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Predicting breast cancer-specific survival in metaplastic breast cancer patients using machine learning algorithms
by: Yufan Feng, et al.
Published: (2023) -
NDRG1 acts as an oncogene in triple-negative breast cancer and its loss sensitizes cells to mitochondrial iron chelation
by: Sukanya B. Jadhav, et al.
Published: (2024) -
METASTASIS OF BREAST CANCER IN THE OVARIES. SURVIVAL AND PROGNOSTIC FACTORS
by: S. N. Tadzhibov, et al.
Published: (2017) -
Metastasis of breast cancer to the bone
by: Joanna Wolska, et al.
Published: (2019) -
Metastasis of breast cancer to the bone
by: Joanna Wolska, et al.
Published: (2019)